Taken together, these data demonstrate hsp-4 loss of function significantly impacts the ability of xbp-1s gain of function to suppress behavioral and biochemical tauopathy phenotypes observed in the C. elegans Tau (high) background. The gene discussed is MAPT; the disease is tauopathy.